scholarly article | Q13442814 |
P819 | ADS bibcode | 2017PLoSO..1278712B |
P356 | DOI | 10.1371/JOURNAL.PONE.0178712 |
P932 | PMC publication ID | 5451073 |
P698 | PubMed publication ID | 28562631 |
P50 | author | Anwesa Bag | Q96238192 |
P2093 | author name string | Rabi Ranjan Chattopadhyay | |
P2860 | cites work | Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria. | Q53568412 |
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations. | Q54069287 | ||
Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms | Q82943372 | ||
Biofilms: survival mechanisms of clinically relevant microorganisms | Q22299328 | ||
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
Anti-biofilm Activity as a Health Issue | Q26747450 | ||
Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
Mechanisms of biofilm resistance to antimicrobial agents | Q29615293 | ||
Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum | Q33340575 | ||
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms | Q33982871 | ||
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States | Q34110686 | ||
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs | Q34735081 | ||
Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity | Q35201457 | ||
Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets | Q36569969 | ||
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci | Q36752594 | ||
The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. | Q36797847 | ||
Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterised patients in Pondicherry, India | Q42153289 | ||
Isolation and identification of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from hydroalcoholic extract of Terminalia chebula fruits effective against multidrug-resistant uropathogens | Q43704486 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
gentamicin | Q422482 | ||
biofilm | Q467410 | ||
multiple drug resistance | Q643839 | ||
Terminalia chebula | Q3595915 | ||
P304 | page(s) | e0178712 | |
P577 | publication date | 2017-05-31 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Synergistic antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms | |
P478 | volume | 12 |